ELCC 2017 May 5-8, Geneva: Video-Recording Oncoletter - Edited and published by VJONCOLOGY

• Lung cancer: from immunotherapy to precision medicine by David Carbone

  02:38

  David Carbone, MD, PhD, from Ohio State University, Columbus, OH discusses new lung cancer treatments and how they can potentially…

   

  Current treatment options for squamous cell lung cancer by David Gandara

• 02:46

  David Gandara, MD, from the University of California,Sacramento, CA discusses the current treatment options for squamous cell lung cancer (SCLC),…

   

  NSCLC: the increasing need for PD-L1 testing by Keith Kerr

• 02:49

  Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, UK discusses the questions surrounding PD-L1 testing…

   

  Prof. Martin Reck on ELCC 2017 and what makes it a unique lung cancer conference by Martin Reck

• 02:06

  Martin Reck, MD, PhD from the Lungen Clinic Grosshansdorf, Grosshansdorf, Germany explains why the annual meeting of European Lung Cancer…

   

  Targeted therapies for advanced NSCLC by Martin Reck

• 01:24

  Martin Reck, MD, PhD from the Lungen Clinic Grosshansdorf, Grosshansdorf, Germany discusses how targeted therapies for patients with advanced non-small…

   

  Data update in advanced stage NSCLC by Solange Peters

  1:41

  Solange Peters, MD, PhD, from the University of Lausanne, Lausanne, Switzerland discusses the ongoing clinical trials investigating advanced stage non-small cell lung cancer (NSCLC).

   

  Maximizing treatment benefits in NSCLC by Nicolas Girard 

  1:40

  Nicolas Girard, MD, from the University Hospital of Lyon, Lyon, France discusses maximizing treatment benefits in non-small cell lung cancer (NSCLC), and the importance of defining different types of disease progression.

   

  Biomarkers are revolutionizing the treatment landscape for NSCLC by Martin Reck

  0:56
• Martin Reck, MD, PhD from the Lungen Clinic Grosshansdorf, Grosshandsdorf, Germany explains the role of biomarkers in precision medicine for non-small cell lung cancer (NSCLC).

 

 The pathologist in cancer care by Keith Kerr

• 2:14

  Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, Scotland speaks about the increasingly vital role of the pathologist in the diagnosis and treatment of cancer patients.

 

 PD-L1 Agents in the treatment of NSCL by David Gandara

• 1:50

  David Gandara, MD, from the University of California, Davis, CA discusses the results of the OAK trial (NCT02008227) and how they impact the treatment landscape of advanced stage, non-small cell lung cancer (NSCLC).

About VJONCOLOGY: The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology.

This report has been made possible with a payment of VJONCOLOGY